182 related articles for article (PubMed ID: 24222902)
21. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
[TBL] [Abstract][Full Text] [Related]
22. Reduced Albumin Dosing During Large-Volume Paracentesis Is Not Associated with Adverse Clinical Outcomes.
Johnson KB; Mueller JL; Simon TG; Zheng H; King LY; Makar RS; Gervais DA; Chung RT
Dig Dis Sci; 2015 Jul; 60(7):2190-5. PubMed ID: 25724164
[TBL] [Abstract][Full Text] [Related]
23. Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial.
García-Compean D; Blanc P; Larrey D; Daures JP; Hirtz J; Mendoza E; Maldonado H; Michel H
Ann Hepatol; 2002; 1(1):29-35. PubMed ID: 15114293
[TBL] [Abstract][Full Text] [Related]
24. Use of albumin in the management of patients with decompensated cirrhosis. An independent verdict.
Arroyo V; Colmenero J
Dig Liver Dis; 2003 Sep; 35(9):668-72. PubMed ID: 14563192
[TBL] [Abstract][Full Text] [Related]
25. Long-term albumin administration in patients with cirrhosis and ascites: A meta-analysis of randomized controlled trials.
Sandi BB; Leão GS; de Mattos AA; de Mattos ÂZ
J Gastroenterol Hepatol; 2021 Mar; 36(3):609-617. PubMed ID: 32914468
[TBL] [Abstract][Full Text] [Related]
26. Standardizing the Use of Albumin in Large Volume Paracentesis.
Anderson SS; McCreary JB; Alvarez KS; Brown LS; Agrawal D
J Pharm Pract; 2020 Aug; 33(4):420-424. PubMed ID: 30522384
[TBL] [Abstract][Full Text] [Related]
27. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites.
Titó L; Ginès P; Arroyo V; Planas R; Panés J; Rimola A; Llach J; Humbert P; Badalamenti S; Jiménez W
Gastroenterology; 1990 Jan; 98(1):146-51. PubMed ID: 2293573
[TBL] [Abstract][Full Text] [Related]
28. Use of albumin in patients with cirrhosis: misuse or misconception?
Kumar R
Natl Med J India; 2011; 24(2):123-4. PubMed ID: 21668072
[No Abstract] [Full Text] [Related]
29. Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis undergoing large-volume paracentesis?
Bernardi M; Caraceni P; Navickis RJ
Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):191-192. PubMed ID: 28004601
[No Abstract] [Full Text] [Related]
30. Effects of midodrine in patients with ascites due to cirrhosis: Systematic review and meta-analysis.
Guo TT; Yang Y; Song Y; Ren Y; Liu ZX; Cheng G
J Dig Dis; 2016 Jan; 17(1):11-9. PubMed ID: 26630543
[TBL] [Abstract][Full Text] [Related]
31. TIPS versus paracentesis for cirrhotic patients with refractory ascites.
Saab S; Nieto JM; Lewis SK; Runyon BA
Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD004889. PubMed ID: 17054221
[TBL] [Abstract][Full Text] [Related]
32. Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis.
Altman C; Bernard B; Roulot D; Vitte RL; Ink O
Eur J Gastroenterol Hepatol; 1998 Jan; 10(1):5-10. PubMed ID: 9512946
[TBL] [Abstract][Full Text] [Related]
33. Can we predict early renal impairment in pediatric cirrhosis?
Prasad D; Sen Sarma M; Yachha SK; Prasad R; Srivastava A; Poddar U; Kumar A
Indian J Gastroenterol; 2022 Apr; 41(2):135-142. PubMed ID: 35067841
[TBL] [Abstract][Full Text] [Related]
34. Albumin in the management of hepatic encephalopathy: A systematic review and meta-analysis.
Is B; Bombassaro IZ; Tovo CV; de Mattos ÂZ; Ahlert M; Chiesa T; de Mattos AA
Ann Hepatol; 2021 Dec; 26():100541. PubMed ID: 34600143
[TBL] [Abstract][Full Text] [Related]
35. Albumin for cirrhotic patients with extraperitoneal infections: A meta-analysis.
Leão GS; John Neto G; Jotz RF; Mattos AA; Mattos ÂZ
J Gastroenterol Hepatol; 2019 Dec; 34(12):2071-2076. PubMed ID: 31353630
[TBL] [Abstract][Full Text] [Related]
36. TIPS versus paracentesis for cirrhotic patients with refractory ascites.
Saab S; Nieto JM; Ly D; Runyon BA
Cochrane Database Syst Rev; 2004; (3):CD004889. PubMed ID: 15266548
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and Safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: A systematic review and meta-analysis.
Wong YJ; Qiu TY; Tam YC; Mohan BP; Gallegos-Orozco JF; Adler DG
Dig Liver Dis; 2020 Oct; 52(10):1137-1142. PubMed ID: 32586766
[TBL] [Abstract][Full Text] [Related]
38. [Albumin infusion for paracentesis in patients with cirrhosis: dogma or evidence?].
Manzocchi S; Nendaz M; Spahr L
Rev Med Suisse; 2012 Oct; 8(358):1956, 1958-60. PubMed ID: 23198648
[TBL] [Abstract][Full Text] [Related]
39. Albumin infusion fails to restore circulatory function following paracentesis of tense ascites as assessed by beat-to-beat haemodynamic measurements.
Schneditz D; Bachler I; Stadlbauer V; Stauber RE
Int J Clin Pract; 2008 Dec; 62(12):1851-7. PubMed ID: 17927765
[TBL] [Abstract][Full Text] [Related]
40. Safety, complications and outcome of large volume paracentesis with or without albumin therapy in children with severe ascites due to liver disease.
Sen Sarma M; Yachha SK; Bhatia V; Srivastava A; Poddar U
J Hepatol; 2015 Nov; 63(5):1126-32. PubMed ID: 26134185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
